WOCKPHARMA - Swing Trade Analysis with AI Signals
← Back to ListKey Parameters
⭐ Swing Trade Rating: 3.2
✅ Positive
Wockpharma has demonstrated significant revenue growth in the latest quarter, with PAT increasing by 230% compared to the previous quarter and a robust ROCE of 9.74%. The stock is currently trading at a relatively low P/E ratio compared to its industry peers.
⚠️ Limitation
The high P/E ratio (113) indicates that the stock may be overvalued, reflecting investor optimism. Furthermore, a substantial decrease in DII holdings (-1.72%) suggests waning institutional interest, creating potential downside risk.
📉 Company Negative News
Recent news highlights a 1.84% rise for Wockhardt Ltd, but provides no specific insights into Wockpharma's performance beyond general market trends.
📈 Company Positive News
None found
🏭 Industry
The pharmaceutical industry is generally considered stable and resilient, driven by increasing healthcare demand globally. However, it’s also subject to regulatory changes and patent expirations which can impact profitability.
🧾 Conclusion
A potential entry price could be around 1950 ₹, targeting a breakout above the resistance at 2422 ₹. Exit guidance would be based on a breach of support at 1846 ₹ or a sustained decline in RSI below 60. Overall, this stock presents moderate swing trading potential due to its volatile growth trajectory and high valuation.